Xuesong Sun

发表

Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy

Jiangtao Liang, H. Mai, Qiu-Yan Chen, 2021, BMC cancer.

The role of artificial intelligence in nasopharyngeal carcinoma radiotherapy

H. Mai, Qiu-Yan Chen, Xuesong Sun, 2020 .

Construction of a comprehensive nutritional index and its correlation with quality of life and survival in patients with nasopharyngeal carcinoma undergoing IMRT: A prospective study.

H. Mai, Yan He, Jian-mei Li, 2019, Oral oncology.

Comprehensive identification of a two-genesignature as a novel potential prognostic model for patients with medulloblastoma.

Lu Gao, B. Xing, Zihao Wang, 2020, American journal of translational research.

Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CT

R. Sun, Xiaofei Lv, H. Mai, 2021, European Journal of Nuclear Medicine and Molecular Imaging.

Identifying optimal candidates for induction chemotherapy among stage II–IVa nasopharyngeal carcinoma based on pretreatment Epstein–Barr virus DNA and nodal maximal standard uptake values of [18F]‐fluorodeoxyglucose positron emission tomography

R. Sun, H. Mai, Qiu-Yan Chen, 2020, Cancer medicine.

Nomogram Predicting the Benefits of Adding Concurrent Chemotherapy to Intensity-Modulated Radiotherapy After Induction Chemotherapy in Stages II–IVb Nasopharyngeal Carcinoma

J. Bei, H. Mai, Qiu-Yan Chen, 2020, Frontiers in Oncology.

Comparison of Gemcitabine Plus Cisplatin vs. Docetaxel Plus Fluorouracil Plus Cisplatin Palliative Chemotherapy for Metastatic Nasopharyngeal Carcinoma

R. Sun, H. Mai, Qiu-Yan Chen, 2020, Frontiers in Oncology.

NasopharyNgeal carciNoma special feature : review article future of radiotherapy in Nasopharyngeal carcinoma

H. Mai, Qiu-Yan Chen, Xuesong Sun, 2019 .

Treatment of nasopharyngeal carcinoma in unique scenarios

H. Mai, Qiu-Yan Chen, Yujing Liang, 2020 .

Endogenous production of C-C motif chemokine ligand 2 by nasopharyngeal carcinoma cells drives radioresistance-associated metastasis.

R. Liu, J. Bei, C. Qian, 2019, Cancer letters.

M1 stage subdivisions based on 18F-FDG PET-CT parameters to identify locoregional radiotherapy for metastatic nasopharyngeal carcinoma

H. Mai, Huan-xin Lin, Ling Guo, 2022, Therapeutic advances in medical oncology.

Geriatric nutritional risk index as an independent prognostic factor in locally advanced nasopharyngeal carcinoma treated using radical concurrent chemoradiotherapy: a retrospective cohort study.

H. Mai, Qiu-Yan Chen, Yujing Liang, 2021, Annals of translational medicine.

Ten-year outcomes of survival and toxicity for a phase III randomised trial of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma.

Ying Sun, Jun Ma, H. Mai, 2019, European journal of cancer.

Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial.

Ying Huang, R. Sun, C. Qian, 2018, The Lancet. Oncology.

Identifying optimal candidates for postoperative adjuvant therapy among regional persistent/recurrent nasopharyngeal carcinoma patients after neck dissection

H. Mai, Qiu-Yan Chen, Lin-Quan Tang, 2022, BMC Cancer.

Comparison of induction chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in Lymph-Node-Stage Nasopharyngeal Carcinoma based on propensity score-matching.

Yan Liu, Xuesong Sun, L. Zeng, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Induction Chemotherapy Plus Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma in Children and Adolescents: A Matched Cohort Analysis

Jun Ma, J. Bei, Chong Zhao, 2018, Cancer research and treatment : official journal of Korean Cancer Association.

The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019, Cancer communications.

The prognosis of neck residue nasopharyngeal carcinoma (NPC) patients: results from a case-cohort study

H. Mai, Qiu-Yan Chen, Yujing Liang, 2018, Journal of Cancer.

Establishment of a prognostic scoring model for regional recurrent nasopharyngeal carcinoma after neck dissection

H. Mai, Xiang Guo, Qiu-Yan Chen, 2020, Cancer biology & medicine.

The development of radiotherapy, image technology and chemotherapy prolongs the survival of patients with nasopharyngeal carcinoma: a cohort study with 20305 patients from 1990 to 2012.

Jun Ma, H. Mai, Qiu-Yan Chen, 2019, International journal of radiation oncology, biology, physics.

Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma

H. Mai, Qiu-Yan Chen, Yujing Liang, 2018, BMC Cancer.

Effect of local treatment for metastasis and its sequence with chemotherapy on prognosis of post-treatment metastatic nasopharyngeal carcinoma patients.

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019, Oral oncology.

Patterns of Failure and Survival Trends in 3,808 Patients with Stage II Nasopharyngeal Carcinoma Diagnosed from 1990 to 2012: A Large-Scale Retrospective Cohort Study

Jun Ma, H. Mai, M. Hong, 2019, Cancer research and treatment : official journal of Korean Cancer Association.

Development and validation of a normal tissue complication probability model for acquired nasal cavity stenosis and atresia after radical radiotherapy for nasopharyngeal carcinoma.

H. Mai, Qiu-Yan Chen, Yujing Liang, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Combinatorial strategies of radiotherapy in the management of nasopharyngeal carcinoma.

H. Mai, Qiu-Yan Chen, Xuesong Sun, 2019, The British journal of radiology.

A new prognostic model for predicting outcomes of patients with recurrent or metastatic nasopharyngeal carcinoma receiving subsequent line (≥2 lines) anti-programmed death-1 monotherapy.

H. Mai, Sailan Liu, Liting Liu, 2023, Oral oncology.

Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I–II nasopharyngeal carcinoma: a nest case-control study

R. Sun, Xiaofei Lv, H. Mai, 2021, European Radiology.

Optimizing the Treatment Pattern for De Novo Metastatic Nasopharyngeal Carcinoma Patients: A Large-Scale Retrospective Cohort Study

R. Sun, H. Mai, Qiu-Yan Chen, 2020, Frontiers in Oncology.

Establishment and Validation of a Nomogram for Nasopharyngeal Carcinoma Patients Concerning the Prognostic Effect of Parotid Lymph Node Metastases

Ling Guo, Sailan Liu, Xuesong Sun, 2020, Cancer research and treatment : official journal of Korean Cancer Association.

Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy response.

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein–Barr virus DNA level and tumor response to palliative chemotherapy

Jun Ma, H. Mai, Qiu-Yan Chen, 2019, BMC Cancer.

SYPL1 Inhibits Apoptosis in Pancreatic Ductal Adenocarcinoma via Suppression of ROS-Induced ERK Activation

Sheng-ping Li, Jiali Wu, Chaobin He, 2020, Frontiers in Oncology.

Increased Angiogenin Expression Correlates With Radiation Resistance and Predicts Poor Survival for Patients With Nasopharyngeal Carcinoma

H. Mai, Qiu-Yan Chen, Yujing Liang, 2021, Frontiers in Pharmacology.

Combinatorial strategies of radiotherapy in the management of nasopharyngeal carcinoma.

H. Mai, Qiu-Yan Chen, Xuesong Sun, 2019, The British journal of radiology.

Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma

H. Mai, Qiu-Yan Chen, Yujing Liang, 2018, BMC Cancer.

Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority Trial

R. Sun, Qing Liu, Chong Zhao, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pulmonary Metastasectomy in Patients with Lung Metastases from Nasopharyngeal Carcinoma

H. Long, Xuesong Sun, Di-Han Liu, 2021, Annals of Surgical Oncology.

Efficacy of Transnasal Endoscopic Fine‐Needle Aspiration Biopsy in Diagnosing Submucosal Nasopharyngeal Carcinoma

H. Mai, Qiu-Yan Chen, Dong-Xiang Wen, 2021, The Laryngoscope.

Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open-label, dose-escalation Study

Qingmei He, Na Liu, Jun Ma, 2018, Cancer communications.

Symptomatic venous thromboembolism associated with peripherally inserted central catheters predicts a worse survival in nasopharyngeal carcinoma: results of a large cohort, propensity score–matched analysis

H. Mai, Qiu-Yan Chen, Yujing Liang, 2018, BMC Cancer.

Pretreatment Serum Amyloid A and C-reactive Protein Comparing with Epstein-Barr Virus DNA as Prognostic Indicators in Patients with Nasopharyngeal Carcinoma: A Prospective Study

R. Sun, C. Qian, Xiang Guo, 2017, Cancer research and treatment : official journal of Korean Cancer Association.

Neoadjuvant or Adjuvant Chemotherapy Plus Concurrent CRT Versus Concurrent CRT Alone in the Treatment of Nasopharyngeal Carcinoma: A Study Based on EBV DNA.

Jun Ma, J. Shao, J. Bei, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Combining pretreatment plasma Epstein‐Barr virus DNA level and cervical node necrosis improves prognostic stratification in patients with nasopharyngeal carcinoma: A cohort study

H. Mai, H. Mo, Qiu-Yan Chen, 2019, Cancer medicine.

Can the prognosis of individual patients with nasopharyngeal carcinoma be predicted using a routine blood test at admission?

Chen Liu, H. Mai, Sailan Liu, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The role of capecitabine as maintenance therapy in de novo metastatic nasopharyngeal carcinoma: A propensity score matching study

H. Mai, Qiu-Yan Chen, Yujing Liang, 2020, Cancer communications.

The development of radiotherapy, image technology and chemotherapy prolongs the survival of patients with nasopharyngeal carcinoma: a cohort study with 20305 patients from 1990 to 2012.

Jun Ma, H. Mai, Qiu-Yan Chen, 2019, International journal of radiation oncology, biology, physics.

Establishment and validation of two nomograms to predict the benefit of concurrent chemotherapy in stage II‐IVa nasopharyngeal carcinoma patients with different risk factors: Analysis based on a large cohort

H. Mai, Qiu-Yan Chen, Sailan Liu, 2020, Cancer medicine.

Establishment and validation of a nomogram for predicting the benefit of concurrent chemotherapy in stage II nasopharyngeal carcinoma: A study based on a phase III randomized clinical trial with 10-year follow-up.

H. Mai, Qiu-Yan Chen, Sailan Liu, 2019, Oral oncology.

Do all patients with locoregionally advanced nasopharyngeal carcinoma benefit from the maintenance chemotherapy using S-1/capecitabine?

H. Mai, Qiu-Yan Chen, Liting Liu, 2021, Oral oncology.

Development and validation of the immune signature to predict distant metastasis in patients with nasopharyngeal carcinoma

R. Sun, H. Mai, Qiu-Yan Chen, 2020, Journal for ImmunoTherapy of Cancer.

Maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography compared with Epstein-Barr virus DNA as prognostic indicators in de novo metastatic nasopharyngeal carcinoma patients

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019, BMC Cancer.

Establishment and validation of a recursive partitioning analysis based prognostic model for guiding re-radiotherapy in local recurrence nasopharyngeal carcinoma patients.

R. Sun, H. Mai, Qiu-Yan Chen, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Effect of Concurrent Chemoradiotherapy With Nedaplatin vs Cisplatin on the Long-term Outcomes of Survival and Toxic Effects Among Patients With Stage II to IVB Nasopharyngeal Carcinoma

R. Sun, H. Mai, H. Mo, 2021, JAMA network open.

Stratification of Candidates for Induction Chemotherapy in Stage III-IV Nasopharyngeal Carcinoma: A Large Cohort Study Based on a Comprehensive Prognostic Model

H. Mai, Qiu-Yan Chen, Sailan Liu, 2020, Frontiers in Oncology.

Establishment of an integrated model for predicting survival and guiding treatment in local recurrence nasopharyngeal carcinoma

R. Sun, H. Mai, Qiu-Yan Chen, 2020 .

Establishment of a prognostic nomogram to identify optimal candidates for local treatment among patients with local recurrent nasopharyngeal carcinoma.

R. Sun, H. Mai, Qiu-Yan Chen, 2020, Oral oncology.

Induction chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in the treatment of different risk locoregionally advanced nasopharyngeal carcinoma

H. Mai, H. Mo, Qiu-Yan Chen, 2020, Therapeutic advances in medical oncology.

Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein–Barr virus DNA level

H. Mai, Qiu-Yan Chen, Yujing Liang, 2020, BMC Cancer.

Establishment and validation of a nomogram for predicting survival in patients with de novo metastatic nasopharyngeal carcinoma.

Jun Ma, H. Mai, Qiu-Yan Chen, 2019, Oral oncology.

Role of zoledronic acid in nasopharyngeal carcinoma patients with bone-only metastasis at diagnosis.

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019, Oral oncology.

Development and validation of a transcriptomics-based gene signature to predict distant metastasis and guide induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.

J. Bei, H. Mai, Qiu-Yan Chen, 2022, European journal of cancer.

The development of a nomogram to predict post-radiation necrosis in nasopharyngeal carcinoma patients: a large-scale cohort study

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019, Cancer management and research.

The development of a nomogram to predict post-radiation necrosis in nasopharyngeal carcinoma patients: a large-scale cohort study

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019 .

Subdivision of de novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment Epstein-Barr virus DNA for therapeutic guidance of primary tumor radiotherapy

Jiangtao Liang, H. Mai, Qiu-Yan Chen, 2021 .

Subdivision of Nasopharyngeal Carcinoma Patients with Bone-Only Metastasis at Diagnosis for Prediction of Survival and Treatment Guidance

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019, Cancer research and treatment : official journal of Korean Cancer Association.

Nasopharyngeal necrosis contributes to overall survival in nasopharyngeal carcinoma without distant metastasis: a comprehensive nomogram model

R. Sun, Zhi-wen Xiao, H. Mai, 2023, European Radiology.

The impact of Adult Comorbidity Evaluation-27 on the clinical outcome of elderly nasopharyngeal carcinoma patients treated with chemoradiotherapy or radiotherapy: a matched cohort analysis

Xiao-Dan Lin, H. Mai, Qiu-Yan Chen, 2019, Journal of Cancer.

Individualized concurrent chemotherapy by pretreatment plasma Epstein‐Barr viral DNA in II‐III stage nasopharyngeal carcinoma: A propensity score matching analysis using a large cohort

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019, Cancer medicine.

Definitive radiation therapy and liver local therapy in de novo liver metastatic nasopharyngeal carcinoma: Large cohort study

H. Mai, Qiu-Yan Chen, Zhen-Chong Yang, 2022, Head & neck.

Novel prognostic model for stratifying survival in stage I lung adenocarcinoma patients

H. Long, Xuesong Sun, Zheng-Hao Ye, 2019, Journal of Cancer Research and Clinical Oncology.

Jun Ma, H. Mai, Qiu-Yan Chen, 2019, BMC Cancer.

Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.

Ying Huang, R. Sun, Chong Zhao, 2023, The Lancet. Oncology.

Head and neck MRI-based T stage and [^18F]FDG PET/CT-based N/M stage improved prognostic stratification in primary nasopharyngeal carcinoma

Li-Zhi Liu, Xiaofei Lv, Ruhai Zou, 2023, European Radiology.

Intensive Local Radiotherapy Is Associated With Better Local Control and Prolonged Survival in Bone-Metastatic Nasopharyngeal Carcinoma Patients

R. Sun, H. Mai, H. Mo, 2020, Frontiers in Oncology.

Proposed prognostic subgroups and facilitated clinical decision-making for additional locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: a retrospective study based on recursive partitioning analysis

H. Hong, Xuesong Sun, Zhao Wang, 2023, Radiation Oncology.

Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on plasma Epstein–Barr virus DNA level after induction chemotherapy

R. Sun, H. Mai, Qiu-Yan Chen, 2020, Aging.

Clinical characteristics and prognostic factors affecting survival after radical radiotherapy for early and late post-treatment metastatic nasopharyngeal carcinoma

H. Mai, Qiu-Yan Chen, Sailan Liu, 2023, BMC Cancer.

H. Mai, Qiu-Yan Chen, Yujing Liang, 2018, BMC Cancer.

Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial

Xiaofei Lv, M. Zeng, H. Mai, 2023, Nature communications.

Percent change in apparent diffusion coefficient and plasma EBV DNA after induction chemotherapy identifies distinct prognostic response phenotypes in advanced nasopharyngeal carcinoma

Chuan-miao Xie, R. Sun, H. Mai, 2021, BMC Cancer.

Palliative chemotherapy with or without anti-EGFR therapy for de novo metastatic nasopharyngeal carcinoma: a propensity score-matching study

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019, Drug design, development and therapy.

Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial.

R. Sun, Chong Zhao, H. Mai, 2023, European journal of cancer.

Paclitaxel liposome, cisplatin and 5-fluorouracil-based induction chemotherapy followed by de-escalated intensity-modulated radiotherapy with concurrent cisplatin in stage IVA–IVB childhood nasopharyngeal carcinoma in endemic area: a phase II, single-arm trial

Wan-Ping Guo, H. Mai, H. Mo, 2023, The Lancet regional health. Western Pacific.

Management of Suboptimal Response to Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Re-induction Therapy or Direct to Radiotherapy?

H. Mai, Qiu-Yan Chen, Yujing Liang, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Individualized concurrent chemotherapy by pretreatment plasma Epstein‐Barr viral DNA in II‐III stage nasopharyngeal carcinoma: A propensity score matching analysis using a large cohort

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019, Cancer medicine.

High Extracellular Matrix Stiffness Promotes the Metastasis of Nasopharyngeal Carcinoma through STAT3/FGF1 Positive Feedback Regulation Activated by JAK2

H. Mai, Qiu-Yan Chen, D. Luo, 2024, Precision Medicine and Engineering.